Atypical Antipsychotics for the Treatment of Delirious Elders

Journal of the American Medical Directors Association

Volumn 9, Issue 1, 2008, Pages 18-28

  Ozbolt, Lauren B ^a   Paniagua, Miguel A ^b   Kaiser, Robert M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical antipsychotics; delirium; elderly

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; GLUCOSE; HALOPERIDOL; LIPID; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PLACEBO; PROLACTIN; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

AGED; AKATHISIA; ANTICHOLINERGIC EFFECT; BEDTIME DOSAGE; BINDING AFFINITY; BLURRED VISION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FOLLOW UP; GALACTORRHEA; GLUCOSE BLOOD LEVEL; HEART ARREST; HEART PALPITATION; HUMAN; HYPERACTIVITY; HYPOTENSION; HYPOTHYROIDISM; LIPID BLOOD LEVEL; LOW DRUG DOSE; MAJOR DEPRESSION; MAXIMUM PERMISSIBLE DOSE; MEDICAL LITERATURE; MEDLINE; MENSTRUAL IRREGULARITY; MORNING DOSAGE; MUSCLE WEAKNESS; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PARKINSONISM; PROLACTIN BLOOD LEVEL; PRURITUS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; STANDING; STOMACH PAIN; SUDDEN DEATH; TARDIVE DYSKINESIA; TORSADE DES POINTES; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VIVID DREAM; WEIGHT GAIN;

EID: 37549000101     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.08.007     Document Type: Review

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed (1994), American Psychiatric Association, Washington, DC 129-133
2. Kaplan H., and Sadock B. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry (1998) MD: Philadelphia, PA Lippincott Williams & Wilkins
3. Katz P.R., Grossberg G.T., Potter J.F., et al. Delirium. Geriatrics Syllabus for Specialists 26 (2002) 2
4. Nayeem K., and O'Keeffe S.T. CME elderly medicine. Clin Med 3 5 (2003) 412-415
5. Inouye S.K. Delirium in older persons. N Engl J Med 354 11 (2006) 1157-1165
6. Thorp L. The treatment of psychotic disorders in late life. Can J Psychiatry 42 Suppl 1 (1997) 19S-27S
7. Mittal D., Jimerson N.A., Neely E.P., et al. Risperidone in the treatment of delirium: Results from a prospective open-label trial. J Clin Psychiatry 65 5 (2004) 662-667
8. Han C., and Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45 4 (2004) 297-301
9. Nassisi D., Korc B., Hahn S., et al. The evaluation and management of the acutely agitated elderly patient. Mt Sinai J Med 73 7 (2006) 976-984
10. Targum S.D. Treating psychotic symptoms in elderly patients. Primary Care Companion. J Clin Psychiatry 3 4 (2001) 156-163
11. Jackson J.C. Delirium and long-term cognitive impairment: An overview. Clinical Window Web Journal: Outcome after Intensive Care Delirium, #21, Vol. 6, January 2006. http://www.clinicalwindow.net Accessed July 27, 2007
12. Rathier M.O., and McElhaney J. Delirium in elderly patients: How you can help. Applied Neurology (2005) August
13. Schwartz T.L., and Masand P.S. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43 3 (2002) 171-173
14. Flaherty J.H., Rudolph J., Shay K., et al. Delirium is a serious and under-recognized problem: Why assessment of mental status should be the sixth vital sign. J Am Med Dir Assoc (2007) 273-275
15. Shingo M., Yamamoto K., Hoshino S., et al. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry Clin Neurosci 61 (2007) 275-282
16. Lacasse H., Perreault M.M., and Williamson D.R. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 40 (2006) 1966-1973
17. Sipahimalani A., and Masand P. Use of risperidone in delirium: Case reports. Ann Clin Psychiatry 9 2 (1997) 105-107
18. Bourgeois J.A., and Hilty D.M. Prolonged delirium managed with risperidone. Psychosomatics 46 1 (2005) 90-91
19. Ravona-Springer R., Dolberg O.T., Hirschmann S., et al. Delirium in elderly patients treated with risperidone: A report of three cases. J Clin Psychopharmacol 18 2 (1998) 171-172
20. Horikawa N., Yamazaki T., Miyamoto K., et al. Treatment of delirium with risperidone: Results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 25 4 (2003) 289-292
21. Zarate C.A., Baldessarini R.J., Siegel A.J., et al. Risperidone in the elderly: A pharmacoepidemiologic study. J Clin Psychiatry 58 7 (1997) 311-317
22. Gupta N., Sharma P., and Mattoo S.K. Effectiveness of risperidone in delirium. Can J Psychiatry 50 (2005) 75
23. Lim C.J., Trevino C., and Tampi R.R. Can olanzapine cause delirium in the elderly?. Ann Pharmacother 40 (2006) 135-138
24. Skrobik Y., Bergeron N., Dumont M., et al. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intens Care Med 30 (2004) 444-449
25. Breitbart W., Tremblay A., and Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43 3 (2002) 175-182
26. Kim K., Pae C., Chae J., et al. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 55 (2001) 515-519
27. Sipahimalani A., and Masand P.S. Olanzapine in the treatment of delirium. Psychosomatics 39 (1998) 422-430
28. Kim K.Y., Bader G.M., Kotlyar V., et al. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 16 1 (2003) 29-32
29. Sasaki Y., Matsuyama T., Inoue S., et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 64 11 (2003) 1316-1321
30. Neil W., Curran S., and Wattis J. Antipsychotic prescribing in older people. Age Ageing 32 5 (2003) 475-483
31. Zayas E.M., and Grossberg G.T. The treatment of psychosis in later life. J Clin Psychiatry 59 suppl 1 (1998) 5-10
32. Mosby's Drug Consult. Mosby, Inc (2006). http://www.mdconsult.com Accessed February 16, 2006
33. Schneider L.S., Dagerman K.S., and Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 294 (2005) 1934-1943
34. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353 22 (2005) 2335-2341
35. Herrmann N., Mamdani M., and Lanctot K. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161 6 (2004) 1113-1115
36. Glassman A.H., and Bigger J.T. Antipsychotic drugs: Prolonged QTc interval, Torsade de Pointes, and sudden death. Am J Psychiatry 158 (2001) 1774-1782
37. Gill S.S., Rochon P.A., Herrmann N., et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. BMJ 330 (2005) 445-451
38. Layton D., Harris S., Wilton L., et al. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. J Psychopharmacol 19 5 (2005) 473-482
39. Ryan C.J. Optimising management of delirium. BMJ 322 (2001) 1602
40. Schneider L.S., Tariot P.N., Dagerman K.S., et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 355 15 (2006) 1525-1538
41. Pitkala K.H., Laurila J.V., Strandberg T.E., et al. Multicomponent geriatric intervention for elderly inpatients with delirium: A randomized, controlled trial. J Gerontol 61 2 (2006) 176-181
42. Inouye S.K., Bogardus Jr. S.T., Charpentier P.A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340 9 (1999) 669-676